These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 34199766)
1. Differentially Expressed Extracellular Vesicle-Contained microRNAs before and after Transurethral Resection of Bladder Tumors. Strømme O; Heck KA; Brede G; Lindholm HT; Otterlei M; Arum CJ Curr Issues Mol Biol; 2021 Jun; 43(1):286-300. PubMed ID: 34199766 [TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer. Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489 [TBL] [Abstract][Full Text] [Related]
3. Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer. El-Shal AS; Shalaby SM; Abouhashem SE; Elbary EHA; Azazy S; Rashad NM; Sarhan W Mol Biol Rep; 2021 May; 48(5):4361-4371. PubMed ID: 34085193 [TBL] [Abstract][Full Text] [Related]
4. Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients. Ozawa PMM; Vieira E; Lemos DS; Souza ILM; Zanata SM; Pankievicz VC; Tuleski TR; Souza EM; Wowk PF; Urban CA; Kuroda F; Lima RS; Almeida RC; Gradia DF; Cavalli IJ; Cavalli LR; Malheiros D; Ribeiro EMSF Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963351 [TBL] [Abstract][Full Text] [Related]
5. Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study. Lu C; Lin S; Wen Z; Sun C; Ge Z; Chen W; Li Y; Zhang P; Wu Y; Wang W; Chen S; Zhou H; Li X; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Wu X; Lai Y Biomarkers; 2024 Jul; 29(5):276-284. PubMed ID: 38767408 [TBL] [Abstract][Full Text] [Related]
6. tRNA-Derived Fragments as Biomarkers in Bladder Cancer. Strømme O; Heck KA; Brede G; Lindholm HT; Otterlei M; Arum CJ Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672670 [TBL] [Abstract][Full Text] [Related]
7. miR-182, miR-221 and miR-222 are potential urinary extracellular vesicle biomarkers for canine urothelial carcinoma. Karttunen J; Kalmar L; Grant A; Ying J; Stewart SE; Wang X; Frankl FK; Williams T Sci Rep; 2024 Aug; 14(1):17967. PubMed ID: 39095540 [TBL] [Abstract][Full Text] [Related]
8. Investigating miR-6880-5p in extracellular vesicle from plasma as a prognostic biomarker in endocrine therapy-treated castration-resistant prostate cancer. Lee J; Hong J; Kim JW; Lim S; Choi SC; Gim JA; Kang SG; Noh TI; Park KH BMC Cancer; 2024 Jul; 24(1):909. PubMed ID: 39075471 [TBL] [Abstract][Full Text] [Related]
9. The value of urinary exosomal microRNA-21 in the early diagnosis and prognosis of bladder cancer. Yang FK; Tian C; Zhou LX; Guan TY; Chen GL; Zheng YY; Cao ZG Kaohsiung J Med Sci; 2024 Jul; 40(7):660-670. PubMed ID: 38801488 [TBL] [Abstract][Full Text] [Related]
10. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer. Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907 [TBL] [Abstract][Full Text] [Related]
11. Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study. Spagnuolo M; Costantini M; Ferriero M; Varmi M; Sperduti I; Regazzo G; Cicchillitti L; Díaz Méndez AB; Cigliana G; Pompeo V; Russo A; Laquintana V; Mastroianni R; Piaggio G; Anceschi U; Brassetti A; Bove A; Tuderti G; Flammia RS; Gallucci M; Simone G; Rizzo MG J Exp Clin Cancer Res; 2020 Apr; 39(1):68. PubMed ID: 32303246 [TBL] [Abstract][Full Text] [Related]
12. A urinary microRNA (miR) signature for diagnosis of bladder cancer. Hofbauer SL; de Martino M; Lucca I; Haitel A; Susani M; Shariat SF; Klatte T Urol Oncol; 2018 Dec; 36(12):531.e1-531.e8. PubMed ID: 30322728 [TBL] [Abstract][Full Text] [Related]
13. Circulating miRNA panels for specific and early detection in bladder cancer. Usuba W; Urabe F; Yamamoto Y; Matsuzaki J; Sasaki H; Ichikawa M; Takizawa S; Aoki Y; Niida S; Kato K; Egawa S; Chikaraishi T; Fujimoto H; Ochiya T Cancer Sci; 2019 Jan; 110(1):408-419. PubMed ID: 30382619 [TBL] [Abstract][Full Text] [Related]
14. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer. Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263 [TBL] [Abstract][Full Text] [Related]
15. Plasma microRNA profiles for bladder cancer detection. Adam L; Wszolek MF; Liu CG; Jing W; Diao L; Zien A; Zhang JD; Jackson D; Dinney CP Urol Oncol; 2013 Nov; 31(8):1701-8. PubMed ID: 22863868 [TBL] [Abstract][Full Text] [Related]
16. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer. Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772 [TBL] [Abstract][Full Text] [Related]
17. Plasma Extracellular Vesicle miRNAs Can Identify Lung Cancer, Current Smoking Status, and Stable COPD. O'Farrell HE; Bowman RV; Fong KM; Yang IA Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071592 [TBL] [Abstract][Full Text] [Related]
18. Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection. Sasaki H; Yoshiike M; Nozawa S; Usuba W; Katsuoka Y; Aida K; Kitajima K; Kudo H; Hoshikawa M; Yoshioka Y; Kosaka N; Ochiya T; Chikaraishi T Clin Genitourin Cancer; 2016 Oct; 14(5):e493-e499. PubMed ID: 27157639 [TBL] [Abstract][Full Text] [Related]
19. EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer. Roman-Canal B; Tarragona J; Moiola CP; Gatius S; Bonnin S; Ruiz-Miró M; Sierra JE; Rufas M; González E; Porcel JM; Gil-Moreno A; Falcón-Pérez JM; Ponomarenko J; Matias-Guiu X; Colas E J Transl Med; 2019 Jun; 17(1):208. PubMed ID: 31221189 [TBL] [Abstract][Full Text] [Related]